Sunday, December 07, 2025 | 04:52 AM ISTहिंदी में पढें
Usfda Issues Warning Letter To Lupin
Lupin falls 3% as USFDA issues 5 observations for Vizag facility
The United States Food and Drug Administration (USFDA) carried out the inspection of the company's Vizag API manufacturing facility between January 13, 2020 and January 17, 2020.
 "Lupin falls 3% as USFDA issues 5 observations for Vizag facility")
Updated On : 20 Feb 2020 | 10:25 AM IST
USFDA issues warning letter to Lupin's Goa, Indore plants
USFDA issued a warning letter to Lupin for violation of current good manufacturing practice norms at two of its manufacturing facilities in Goa and Indore
 "USFDA issues warning letter to Lupin's Goa, Indore plants")
Updated On : 16 Nov 2017 | 7:39 PM IST
